CLAZAKIZUMAB (ANTI-IL-6) INDUCES FOXP3+ TREGS IN HIGHLY HLA SENSITIZED PATIENTS RECEIVING HLAI KIDNEY TRANSPLANTATION (NCT03380962)

Authors :: Alice Peng
Nori Ammerman
Kathlyn Lim
Supreet Sethi
Kate Myers
Summer Williamson
Edmund Huang
Reiad Najjar
Stanley C. Jordan
Shili Ge
Mieko Toyoda
Ashley Vo
Jua Choi
Source :: Transplantation. 104:S105-S105
Publication Year :: 2020
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2020.

Subjects :: Transplantation
Clazakizumab
business.industry
Immunology
medicine
FOXP3
Anti-IL-6
Human leukocyte antigen
medicine.disease
business
Kidney transplantation

Tools